Vaccine adjuvant protects against post-burn infection
Research findings published in the April 2016 issue of the Journal of Leukocyte Biology, suggests that the use of a FDA-approved drug may serve a dual purpose by protecting people who are at high risk of infection, including ...
Apr 1, 2016
0
9